PHS
PFE icon

PFM Health Sciences’s Pfizer PFE Stock Holding History

PFM Health Sciences’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,343,384
Closed -$70.4M – 90
2022
Q2 		$70.4M Hold
1,343,384
– – 2.69% 10
2022
Q1 		$69.5M Hold
1,343,384
– – 2.6% 13
2021
Q4 		$79.3M Buy
+1,343,384
New +$66.6M 2.7% 9
2021
Q1 		– Sell
-685,125
Closed -$25.2M – 104
2020
Q4 		$25.2M Buy
685,125
+180,933
+36% +$6.64M 0.89% 45
2020
Q3 		$17.6M Buy
+504,192
New +$17.7M 0.81% 46
2020
Q2 		– Sell
-1,244,414
Closed -$38.5M – 85
2020
Q1 		$38.5M Buy
1,244,414
+271,439
+28% +$9.25M 3.17% 9
2019
Q4 		$36.2M Buy
+972,975
New +$34.7M 1.72% 21
2019
Q3 		– Sell
-1,720,850
Closed -$70.7M – 94
2019
Q2 		$70.7M Sell
1,720,850
-1,265,233
-42% -$50.2M 1.34% 24
2019
Q1 		$120M Buy
2,986,083
+2,002,189
+203% +$80.2M 2.66% 5
2018
Q4 		$40.7M Buy
+983,894
New +$40.8M 1.08% 36
2017
Q4 		– Sell
-1,613,081
Closed -$54.6M – 96
2017
Q3 		$54.6M Buy
+1,613,081
New +$51.8M 1.07% 35
2015
Q4 		– Sell
-5,564,481
Closed -$166M – 83
2015
Q3 		$166M Buy
5,564,481
+5,232,819
+1,578% +$168M 4.66% 5
2015
Q2 		$10.6M Sell
331,662
-2,074,486
-86% -$67.6M 0.27% 67
2015
Q1 		$79.4M Buy
2,406,148
+2,301,249
+2,194% +$73.2M 2.19% 13
2014
Q4 		$3.1M Buy
+104,899
New +$3.01M 0.07% 84
2014
Q2 		– Sell
-1,272,050
Closed -$38.8M – 74
2014
Q1 		$38.8M Buy
1,272,050
+391,862
+45% +$11.7M 0.7% 40
2013
Q4 		$25.6M Sell
880,188
-2,758,675
-76% -$80.3M 0.51% 43
2013
Q3 		$99.2M Sell
3,638,863
-7,541,157
-67% -$205M 2.39% 17
2013
Q2 		$297M Buy
+11,180,020
New +$309M 6.17% 3

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PFM Health Sciences's PFE Position: Q3 2022 in Review

PFM Health Sciences sold out of Pfizer (PFE) in Q3 2022, closing a stake of 1,343,384 shares — an estimated $70.4M sold.

PFM Health Sciences first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $297M in Q2 2013. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • PFM Health Sciences reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • PFM Health Sciences sold 1,343,384 Pfizer shares in Q3 2022, an estimated $70.4M.
  • PFM Health Sciences first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • PFM Health Sciences's Pfizer position peaked at $297M in Q2 2013.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on PFM Health Sciences's 13F filing for Q3 2022, filed 14 Nov 2022.